CRISPR Therapeutics AG short interest in 2024
In 2024, CRISPR Therapeutics AG's disclosed short interest ran from 21.45% of shares outstanding on 12 Jan 2024 to 22.37% on 31 Dec 2024, a change of +0.92 percentage points. The year's high was 22.72% on 15 Nov 2024 and its low 17.51% on 14 Jun 2024, averaging 19.82% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.97 days on 30 Aug 2024. Full history: CRISPR Therapeutics AG.
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 21.45% (12 Jan 2024)
- End of year
- 22.37% (31 Dec 2024)
- Change
- +0.92 pp
- High
- 22.72% (15 Nov 2024)
- Low
- 17.51% (14 Jun 2024)
- Average
- 19.82%
- Highest days to cover
- 19.97 (30 Aug 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 21.45% | 7.53 | |
| 31 Jan 2024 | 19.82% | 8.89 | |
| 15 Feb 2024 | 18.73% | 5.97 | |
| 29 Feb 2024 | 18.96% | 5.88 | 10-K filed, results (8-K) |
| 15 Mar 2024 | 18.54% | 10.18 | |
| 28 Mar 2024 | 18.58% | 12.19 | |
| 15 Apr 2024 | 18.56% | 11.56 | |
| 30 Apr 2024 | 18.36% | 11.22 | |
| 15 May 2024 | 18.06% | 9.88 | 10-Q filed, results (8-K) |
| 31 May 2024 | 18.44% | 15.44 | |
| 14 Jun 2024 | 17.51% | 10.27 | |
| 28 Jun 2024 | 18.43% | 10.94 | |
| 15 Jul 2024 | 18.98% | 14.30 | |
| 31 Jul 2024 | 19.35% | 12.21 | |
| 15 Aug 2024 | 20.16% | 11.23 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 20.48% | 19.97 | |
| 13 Sep 2024 | 20.60% | 19.22 | |
| 30 Sep 2024 | 20.62% | 15.28 | |
| 15 Oct 2024 | 20.66% | 18.39 | |
| 31 Oct 2024 | 21.82% | 16.13 | |
| 15 Nov 2024 | 22.72% | 8.97 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 21.27% | 11.54 | |
| 13 Dec 2024 | 21.23% | 8.91 | |
| 31 Dec 2024 | 22.37% | 10.61 |
See also: CRISPR Therapeutics AG's full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.